Related Experiment Video
Updated: Apr 17, 2026
08:09
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
13.1K
Combining endometrium sampling device and SurePath preparation to screen for endometrial carcinoma: a validation
1Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.
Chinese Medical Journal
|February 21, 2015
Summary
Endometrial cytology using SAP-1 sampling and SurePath preparation offers a reliable method for screening endometrial carcinoma. This approach demonstrates high accuracy and specimen adequacy compared to traditional methods.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cytopathology
Background:
- Endometrial sampling is crucial for diagnosing endometrial carcinoma and its precursors.
- Traditional methods like D&C and hysteroscopy for histology have limitations in specimen adequacy and patient comfort.
Purpose of the Study:
- To compare specimen adequacy between SAP-1 cytology and D&C/hysteroscopy histology.
- To evaluate the accuracy of combined SAP-1 endometrial sampling and SurePath liquid-based cytology for endometrial cancer screening.
Main Methods:
- 1514 women with risk factors underwent endometrial sampling with SAP-1 for cytology.
- 375 women also underwent D&C or hysteroscopy for histological analysis.
- Cytological specimens were processed using SurePath liquid-based preparation.
Main Results:
- High specimen adequacy for SAP-1 cytology (96.3%) versus histology (76%).
- Endometrial cytology demonstrated 92.4% accuracy in detecting endometrial carcinoma and precursors.
- SAP-1 sampling was found to be easier than histological specimen collection (P < 0.05).
Conclusions:
- Endometrial cytology with SAP-1 sampling and SurePath preparation is a reliable screening approach.
- This method shows promise for early detection of endometrial carcinoma and its precursor lesions.
